Panagiotis Rigopoulos

Panagiotis Rigopoulos is a skilled professional in the pharmaceutical and healthcare sectors with extensive experience in market access, medical advisory, health economics and outcomes research (HEOR), and pharmacoeconomics. Currently serving as a Market Access Coordinator at VIANEX SA since June 2022, Rigopoulos previously worked as a Medical Advisor and HEOR Consultant at HealThink from September 2020 to May 2022. Prior roles include Pharmacoeconomics Researcher and Teaching Associate at Aristotle University of Thessaloniki from November 2018 to October 2020 and Clinical Study Coordinator at the University General Hospital of Alexandroupoli between August 2016 and November 2018, where responsibilities included managing clinical trials and patient selection. Rigopoulos started as a pharmacist at a Community Pharmacy from October 2015 to August 2016. Educational qualifications include a Postgraduate Degree in Advanced Methods for Cost-effectiveness Analysis from the University of York and a Master of Science in Clinical Pharmacology-Therapeutics from the Democritus University of Thrace, along with a Doctor of Pharmacy from Aristotle University of Thessaloniki.